November 27, 2021: CNBC's chief medical contributor Scott Gottlieb is a "walking conflict of interest" in much the same way Sanjay Gupta is for CNN. These "made-for-tv-doctors" are beholden to their corporate news networks and to their deep affiliations with pharmaceutical companies like Pfizer and regulatory agencies like the FDA. These medical frauds effectively serve the nation's health bureaucracies (FDA, CDC, DHHS, NIH, and NIAID) as bought-and-paid-for government spokespeople.
The next time you watch Scott Gottlieb promoting Pfizer and its products and Covid mandates on CNBC, consider Gottlieb's role on Pfizer's Board of Directors and his former role as Commissioner of the FDA (please refer to his biography provided below). When this spokesperson for the "Covid cartel" presents himself as an objective medical expert, remember the following facts about Gottlieb:
- he is on the Pfizer Board of Directors
- he is an active investor within the Pharmaceautical Industry
- he is the former Commissioner of the FDA
- he is a General Partner at the venture capital firm New Enterprise Associates (NEA)
- he is a paid senior contributor at CNBC and CBS
- he is a member of the Federal Information Technology Policy Committee
The egregious conflicts taht come with Gottlieb are irrefutable. If you are expecting anything other than a complete bias in favor of Covid vaccines, Covid mandates, and allegiance to Pfizer, you are sadly mistaken. Scott Gottlieb is simply another "variant" of Anthony Fauci, only with better "packaging".
Scott Gottlieb Biography
Scott Gottlieb (born June 11, 1972) is an American physician and investor who served as the 23rd commissioner of the Food and Drug Administration (FDA) from 2017 until April 2019. He is presently a senior fellow at the conservative think tank the American Enterprise Institute (AEI), a partner at the venture capital firm New Enterprise Associates (NEA), a member of the board of directors of drug maker Pfizer, a member of the board of directors of Illumina, Inc., a contributor to the cable financial news network CNBC, and a frequent guest on the CBS News program Face the Nation. He is the author of the The New York Times best-selling book Uncontrolled Spread on the COVID-19 pandemic and the national security vulnerabilities that it revealed. Before becoming FDA commissioner, he was a clinical assistant professor at New York University School of Medicine, the FDA deputy commissioner for medical and scientific affairs, a venture partner with New Enterprise Associates, a member of the policy board of the Leukemia & Lymphoma Society, a senior official at the Centers for Medicare and Medicaid Services, and a member of the Federal Health Information Technology Policy Committee, which advises the United States Department of Health and Human Services on healthcare information technology. He was previously a resident fellow at AEI from 2007 to 2017 prior to joining the FDA as commissioner in May 2017.
By: Extremely American Colin Wright